marijuana rescheduling
-
Canopy Growth Stock Surges, Then Slips: What’s Fueling the Cannabis Rollercoaster in 2025?
Canopy Growth’s stock soared on U.S. marijuana rescheduling rumors, then whipsawed as traders weighed real reform against persistent financial hurdles. Here’s what’s driving the volatility—and what investors should watch next.
-
Weed Stocks Surge as Trump Moves to Loosen U.S. Marijuana Restrictions
Weed stocks, led by Canopy Growth, soared after reports that President Trump plans to reclassify marijuana as a less-restricted drug. While investors cheered, questions remain about long-term profitability and the true impact of the policy shift.